Boston, Massachusetts 02215


Purpose:

The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program.


Study summary:

The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program and to determine whether other hospitals would benefit from instituting a similar program. Prior studies have compared the outcome from a DIEP flap program with that of TRAM flaps within the same center. Other studies have calculated the cost of a DIEP flap and its complication rate. However, no one has examined the overall effects of a subspecialized reconstruction program and its impact on a health center. In this study, we will determine if the institutionalization of a DIEP flap program has increased our center's rate of breast reconstruction, as well as evaluate its outcomes and overall financial viability.


Criteria:

Inclusion Criteria: - Intraductal carcinoma - Lobular carcinoma - Infiltrating ductal carcinoma - Paget's disease - BRCA positive Exclusion Criteria: - Inflammatory carcinoma of the breast


NCT ID:

NCT00543907


Primary Contact:

Principal Investigator
Bernard T Lee, MD
Beth Israel Deaconess Medical Center

Bernard T Lee, MD
Phone: 617.632.7835
Email: blee3@bidmc.harvard.edu


Backup Contact:

N/A


Location Contact:

Boston, Massachusetts 02215
United States

Bernard T Lee, MD
Phone: 617-632-7835
Email: blee3@bidmc.harvard.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.